Showing results (41-50 of 255) with videos related to
Sort By:
Pageof 26
Frontiers in Pharmacology|March 29, 2021
Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic DamageAnnalisa Bianco, Serena Pinci, Claudio Tiribelli, et al.Antioxidants (Basel, Switzerland)|September 25, 2020
The Role of Bilirubin and the Other "Yellow Players" in Neurodegenerative DiseasesSri Jayanti, Libor Vítek, Claudio Tiribelli, et al.Scientific Reports|February 5, 2020
Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro modelBeatrice Anfuso, Claudio Tiribelli, Luciano Adorini, et al.Healthcare (Basel, Switzerland)|August 6, 2021
COVID-19 Lockdown Effect on Not Institutionalized Patients with Dementia and CaregiversRita Moretti, Paola Caruso, Mauro Giuffré, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 23, 2016
The molecular basis of jaundice: An old symptom revisitedSilvia Gazzin, Flora Masutti, Libor Vitek, et al.European Journal of Gastroenterology & Hepatology|October 19, 2004
The epidemiology of fatty liverStefano Bellentani, Giorgio Bedogni, Lucia Miglioli, et al.Antioxidants & Redox Signaling|November 4, 2008
The many functions of APE1/Ref-1: not only a DNA repair enzymeGianluca Tell, Franco Quadrifoglio, Claudio Tiribelli, et al.International Journal of Molecular Sciences|July 29, 2023
Inflammation, Dopaminergic Brain and BilirubinSri Jayanti, Camilla Dalla Verde, Claudio Tiribelli, et al.Molecules (Basel, Switzerland)|April 17, 2019
Silybin Modulates Collagen Turnover in an In Vitro Model of NASHBeatrice Anfuso, Pablo J Giraudi, Claudio Tiribelli, et al.Antioxidants (Basel, Switzerland)|August 26, 2023
Bilirubin and Redox Stress in Age-Related Brain DiseasesJohn Paul Llido, Sri Jayanti, Claudio Tiribelli, et al.Pageof 26